Transcription of TAMBOCORTM Injection - Medsafe
{{id}} {{{paragraph}}}
Example: dental hygienist
TAMBOCORTM Injection - Medsafe
NEW ZEALAND DATA SHEET. TAMBOCORTM Injection 1 PRODUCT NAME. tambocor 10 mg/mL Injection 2 QUALITATIVE AND QUANTITATIVE COMPOSITION. Each ampoule contains flecainide acetate 150 mg in acetate buffered Water for Injections BP 15 mL. For the full list of excipients see section 3 PHARMACEUTICAL FORM. Solution for Injection or infusion 4 CLINICAL PARTICULARS. Therapeutic indications tambocor Injection is indicated in patients without structural heart disease when rapid control or short-term prophylaxis of the arrhythmias below is the main clinical requirement, including: ventricular tachyarrhythmias where these are resistant to other treatment;. AV nodal reciprocating tachycardia, arrhythmias associated with Wolff-Parkinson-White Syndrome and similar conditions with accessory pathways;. paroxysmal atrial fibrillation in patients with disabling symptoms.
NEW ZEALAND DATA SHEET TAMBOCORTM Injection TAMBOCOR Page 5 of 15 4.4 Special warnings and precautions for use Mortality In the Cardiac Arrhythmia Suppression Trial (CAST), a long -term, large scale, multi-centre, double-
Loading..
Tags:
Information
Domain:
Source:
Link to this page:
Please notify us if you found a problem with this document: